European organisation for research and treatment of cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer

Journal of Clinical Oncology

Volumn 28, Issue 36, 2010, Pages 5301-5310

  De Ruysscher, Dirk ^a   Faivre Finn, Corinne ^a   Nestle, Ursula ^a   Hurkmans, Coen W ^a   Le Péchoux, Cécile ^a   Price, Allan ^a   Senan, Suresh ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; NAVELBINE; PACLITAXEL;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL RESEARCH; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG CANCER; PATIENT POSITIONING; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT PLANNING; TREATMENT RESPONSE; TUMOR VOLUME;

EUROPE; HUMANS; LUNG NEOPLASMS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC;

EID: 79951893859     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.30.3271     Document Type: Article

References (113)

1. Bentzen SM, Harari PM, Tomé WA, Mehta MP: Radiation oncology advances: An introduction. Cancer Treat Res 139:1-4, 2008
2. Haasbeek CJ, Slotman BJ, Senan S: Radiotherapy for lung cancer: Clinical impact of recent technical advances. Lung Cancer 64:1-8, 2009
3. Auperin A, Le Péchoux C, Rolland E, et al: Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non - small-cell lung cancer. J Clin Oncol 28:2181-2190, 2010
4. Pijls-Johannesma M, De Ruysscher D, Vansteenkiste J, et al: Timing of chest radiotherapy in patients with limited stage small cell lung cancer: A systematic review and meta-analysis of randomised controlled trials. Cancer Treat Rev 33:461-473, 2007 (Pubitemid 47324226)
5. Liao ZX, Komaki RR, Thames HD Jr, et al: Influence of technologic advances on outcomes in patients with unresectable, locally advanced non - small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys 76:775-781, 2010
6. Uno T, Sumi M, Ishihara Y, et al: Changes in patterns of care for limited-stage small-cell lung cancer: Results of the 99-01 patterns of care study - A nationwide survey in Japan. Int J Radiat Oncol Biol Phys 71:414-419, 2008
7. Holloway L: Current practice when treating lung cancer in Australasia. Australas Radiol 51:62-67, 2007
8. Kepka L, Danilova V, Saghatelyan T, et al: Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: Results of an International Atomic Energy Agency (IAEA) survey. Lung Cancer 56:235-245, 2007 (Pubitemid 46591989)
9. Casas F, Viñolas N, Sanchez-Reyes A, et al: Spanish patterns of care for 3D radiotherapy in non - small-cell lung cancer. Int J Radiat Oncol Biol Phys 65:138-142, 2006
10. Guyatt G, Gutterman D, Baumann MH, et al: Grading strength of recommendations and quality of evidence in clinical guidelines: Report from an American College of Chest Physicians task force. Chest 129:174-181, 2006 (Pubitemid 43265259)
11. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al: Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non - small-cell lung cancer. Int J Radiat Oncol Biol Phys 70:685-692, 2008
12. Grutters JP, Kessels AG, Pijls-Johannesma M, et al: Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non - small-cell lung cancer: A meta-analysis. Radiother Oncol 95:32-40, 2010
13. Stephans KL, Djemil T, Reddy CA, et al: Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients. J Thorac Oncol 4:838-844, 2009
14. Baumann P, Nyman J, Hoyer M, et al: Outcome in a prospective phase II trial of medically inoperable stage I non - small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27:3290-3296, 2009
15. Henderson M, McGarry R, Yiannoutsos C, et al: Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non - small-cell lung cancer. Int J Radiat Oncol Biol Phys 72:404-409, 2009
16. Haasbeek CJ, Lagerwaard FJ, de Jaeger K, et al: Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy. Cancer 115:587-594, 2009
17. Timmerman R, McGarry R, Yiannoutsos C, et al: Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24:4833-4839, 2006 (Pubitemid 46630909)
18. Curran WJ SC, Langer CJ, et al: Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol 22:621, 2003 (abstr 2499)
19. Fournel P, Robinet G, Thomas P, et al: Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non - small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancerologie NPC 95-01 Study. J Clin Oncol 23:5910-5917, 2005
20. Furuse K, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non - small-cell lung cancer. J Clin Oncol 17:2692-2699, 1999 (Pubitemid 29415225)
21. Takada M, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20:3054-3060, 2002 (Pubitemid 34791094)
22. Hanna N, Neubauer M, Yiannoutsos C, et al: Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non - small-cell lung cancer: The Hoosier Oncology Group and U.S. Oncology. J Clin Oncol 26:5755-5760, 2008
23. Kelly K, Chansky K, Gaspar LE, et al: Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non - small-cell lung cancer: SWOG S0023. J Clin Oncol 26:2450-2456, 2008
24. Brunelli A, Charloux A, Bolliger CT, et al: ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemoradiotherapy). Eur Respir J 34:17-41, 2009
25. Pallis AG, Gridelli C, van Meerbeeck JP, et al: EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non - small-cell lung cancer in an elderly population. Ann Oncol 21:692-706, 2010
26. Rocha Lima CM, Herndon JE 2nd, Kosty M, et al: Therapy choices among older patients with lung carcinoma: An evaluation of two trials of the Cancer and Leukemia Group B. Cancer 94:181-187, 2002 (Pubitemid 34049057)
27. Schild SE, Stella PJ, Geyer SM, et al: The outcome of combined-modality therapy for stage III non - small-cell lung cancer in the elderly. J Clin Oncol 21:3201-3206, 2003 (Pubitemid 46606250)
28. Timmerman R, Galvin J, Michalski J, et al: Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using stereotactic body radiation therapy in lung cancer. Acta Oncol 45:779-786, 2006 (Pubitemid 44423122)
29. Baba F, Shibamoto Y, Tomita N, et al: Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: Evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results. Radiat Oncol 4:15, 2009
30. Underberg RW, Lagerwaard FJ, Slotman BJ, et al: Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: An analysis of 4DCT datasets. Int J Radiat Oncol Biol Phys 62:554-560, 2005 (Pubitemid 40704475)
31. Liu HH, Balter P, Tutt T, et al: Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 68:531-540, 2007 (Pubitemid 46694175)
32. Heinzerling JH, Anderson JF, Papiez L, et al: Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. Int J Radiat Oncol Biol Phys 70:1571-1578, 2008 (Pubitemid 351417780)
33. Masi L, Casamassima F, Menichelli C, et al: On-line image guidance for frameless stereotactic radiotherapy of lung malignancies by cone beam CT: Comparison between target localization and alignment on bony anatomy. Acta Oncol 47:1422-1431, 2008
34. Panakis N, McNair HA, Christian JA, et al: Defining the margins in the radical radiotherapy of non - small-cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters. Radiother Oncol 87:65-73, 2008
35. Nelson C, Starkschall G, Balter P, et al: Assessment of lung tumor motion and setup uncertainties using implanted fiducials. Int J Radiat Oncol Biol Phys 67:915-923, 2007 (Pubitemid 46215890)
36. Harsolia A, Hugo GD, Kestin LL, et al: Dosimetric advantages of four-dimensional adaptive image-guided radiotherapy for lung tumors using online cone-beam computed tomography. Int J Radiat Oncol Biol Phys 70:582-589, 2008
37. Hurkmans CW, Cuijpers JP, Lagerwaard FJ, et al: Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non - small-cell lung cancer: Report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol 4:1, 2009
38. Van Sörnsen de Koste JR, de Boer HC, et al: Procedures for high precision setup verification and correction of lung cancer patients using CT simulation and digitally reconstructed radiographs. Int J Radiat Oncol Biol Phys 55:804-810, 2003
39. McGibney C: Impact of intravenous contrast on target definition in radiotherapy of non - small-cell lung cancer. Eur J Cancer 37:211, 2001 (suppl)
40. Slotman BJ, Lagerwaard FJ, Senan S: 4D imaging for target definition in stereotactic radiotherapy for lung cancer. Acta Oncol 45:966-972, 2006 (Pubitemid 44423147)
41. Underberg RW, Lagerwaard FJ, Slotman BJ, et al: Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer. Int J Radiat Oncol Biol Phys 63:253-260, 2005 (Pubitemid 41583566)
42. Bosmans G, van Baardwijk A, Dekker A, et al: Time trends in nodal volumes and motion during radiotherapy for patients with stage III non - smallcell lung cancer. Int J Radiat Oncol Biol Phys 71:139-144, 2008 (Pubitemid 351491400)
43. Dieleman EM, Senan S, Vincent A, et al: Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. Int J Radiat Oncol Biol Phys 67:775-780, 2007 (Pubitemid 46215893)
44. Haasbeek CJ, Lagerwaard FJ, Cuijpers JP, et al: Is adaptive treatment planning required for stereotactic radiotherapy of stage I non - small-cell lung cancer? Int J Radiat Oncol Biol Phys 67:1370-1374, 2007
45. Bosmans G, van Baardwijk A, Dekker A, et al: Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non - small-cell lung cancer: A prospective clinical study. Int J Radiat Oncol Biol Phys 66:748-753, 2006 (Pubitemid 44436690)
46. Sonke JJ, Rossi M, Wolthaus J, et al: Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance. Int J Radiat Oncol Biol Phys 74:567-574, 2009
47. Purdie TG, Bissonnette JP, Franks K, et al: Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: Localization, verification, and intrafraction tumor position. Int J Radiat Oncol Biol Phys 68:243-252, 2007 (Pubitemid 46589841)
48. Nestle U, Kremp S, Grosu AL: Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non - small-cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 81:209-225, 2006
49. Boellaard R, Oyen WJ, Hoekstra CJ, et al: The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials. Eur J Nucl Med Mol Imaging 35:2320-2333, 2008
50. Grosu AL, Nestle U, Weber WA: How to use functional imaging information for radiotherapy planning. Eur J Cancer 45:461-463, 2009 (suppl)
51. Grgic A, Nestle U, Schaefer-Schuler A, et al: Nonrigid versus rigid registration of thoracic 18FFDG PET and CT in patients with lung cancer: An intraindividual comparison of different breathing maneuvers. J Nucl Med 50:1921-1926, 2009
52. Weber WA, Petersen V, Schmidt B, et al: Positron emission tomography in non - small-cell lung cancer: Prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol 21:2651-2657, 2003 (Pubitemid 46606307)
53. Harris KM, Adams H, Lloyd DC, et al: The effect on apparent size of simulated pulmonary nodules of using three standard CT window settings. Clin Radiol 47:241-244, 1993 (Pubitemid 23107896)
54. International Association for the Study of Lung Cancer: Staging Manual in Thoracic Oncology. Denver, CO, Editorial Rx Press, 2009
55. Glazer GM, Gross BH, Quint LE, et al: Normal mediastinal lymph nodes: Number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 144:261-265, 1985 (Pubitemid 15168325)
56. Kiyono K, Sone S, Sakai F, et al: The number and size of normal mediastinal lymph nodes: A postmortem study. Am J Radiol 150:771-776, 1988 (Pubitemid 18088243)
57. Hellwig D, Baum RP, Kirsch C: FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: A systematic review. Nuklearmedizin 48:59-69, 2009
58. Belderbos JS, Kepka L, Spring Kong FM, et al: Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: Non - small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 72: 335-342, 2008
59. De Ruysscher D, Wanders S, van Haren E, et al: Selective mediastinal node irradiation based on FDG-PET scan data in patients with non - small-cell lung cancer: A prospective clinical study. Int J Radiat Oncol Biol Phys 62:988-994, 2005 (Pubitemid 40884408)
60. Belderbos JS, Heemsbergen WD, De Jaeger K, et al: Final results of a Phase I/II dose escalation trial in non - small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66:126-134, 2006 (Pubitemid 44175671)
61. De Ruysscher D, Bremer RH, Koppe F, et al: Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: A phase II trial. Radiother Oncol 80:307-312, 2006 (Pubitemid 44397204)
62. van Loon J, De Ruysscher D, Wanders R, et al: Selective nodal irradiation on basis of (18)FDGPET scans in limited-disease small-cell lung cancer: A prospective study. Int J Radiat Oncol Biol Phys 77:329-336, 2010
63. Rosenzweig KE, Fox JL, Yorke E, et al: Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non - small-cell lung carcinoma. Cancer 103:2118-2127, 2005 (Pubitemid 40605120)
64. De Ruysscher D, Wanders R, van Haren E, et al: HI-CHART: A phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non - small-cell lung cancer. Int J Radiat Oncol Biol Phys 71:132-138, 2008 (Pubitemid 351491406)
65. Hayman JA, Martel MK, Ten Haken RK, et al: Dose escalation in non - small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial. J Clin Oncol 19:127-136, 2001 (Pubitemid 32063489)
66. Lagerwaard FJ, van de Vaart PJ, Voet PW, et al: Can errors in reconstructing pre-chemotherapy target volumes contribute to the inferiority of sequential chemoradiation in stage III non - small cell lung cancer? Lung Cancer 38:297-301, 2002
67. International Commission on Radiation Units and Measurements (ICRU): Report 50: Prescribing, recording, and reporting photon beam therapy, in ICRU Report Volume 50. Bethesda, MD, International Commission on Radiation Units and Measurements, 1993
68. International Commission on Radiation Units and Measurements (ICRU): Report 62: Prescribing, recording, and reporting photon beam therapy (supplement to ICRU report 50), in ICRU Report Volume 62. Bethesda, MD, International Commission on Radiation Units and Measurements, 1999
69. Giraud P, Antoine M, Larrouy A, et al: Evaluation of microscopic tumor extension in non - small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 48:1015-1024, 2000
70. Yuan S, Meng X, Yu J, et al: Determining optimal clinical target volume margins on the basis of microscopic extracapsular extension of metastatic nodes in patients with non - small-cell lung cancer. Int J Radiat Oncol Biol Phys 67:727-734, 2007 (Pubitemid 46215861)
71. Spoelstra FO, Senan S, Le Péchoux C, et al: Variations in target volume definition for postoperative radiotherapy in stage III non - small-cell lung cancer: Analysis of an international contouring study. Int J Radiat Oncol Biol Phys 76:1106-1113, 2010
72. Chapet O, Kong FM, Quint LE, et al: CTbased definition of thoracic lymph node stations: An atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 63:170-178, 2005 (Pubitemid 41594455)
73. Wolthaus JW, Sonke JJ, van Herk M, et al: Comparison of different strategies to use four-dimensional computed tomography in treatment planning for lung cancer patients. Int J Radiat Oncol Biol Phys 70:1229-1238, 2008 (Pubitemid 351296128)
74. Bosmans G, Buijsen J, Dekker A, et al: An in silico clinical trial comparing free breathing, slow and respiration correlated computed tomography in lung cancer patients. Radiother Oncol 81:73-80, 2006 (Pubitemid 44512055)
75. Mexner V, Wolthaus JW, van Herk M, et al: Effects of respiration-induced density variations on dose distributions in radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 74:1266-1275, 2009
76. Stroom JC, Heijmen BJ: Limitations of the planning organ at risk volume (PRV) concept. Int J Radiat Oncol Biol Phys 66:279-286, 2006 (Pubitemid 44175673)
77. Knöös T, Wieslander E, Cozzi L, et al: Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations. Phys Med Biol 51:5785-5807, 2006 (Pubitemid 46217668)
78. Schuring D, Hurkmans CW: Developing and evaluating stereotactic lung RT trials: What we should know about the influence of inhomogeneity corrections on dose. Radiat Oncol 3:21, 2008
79. Aarup LR, Nahum AE, Zacharatou C, et al: The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: Implications for tumour coverage. Radiother Oncol 91:405-414, 2009
80. Elmpt W, Ollers M, Velders M, et al: Transition from a simple to a more advanced dose calculation algorithm for radiotherapy of non - small-cell lung cancer (NSCLC): Implications for clinical implementation in an individualized dose-escalation protocol. Radiother Oncol 88:326-334, 2008
81. Morgan AM, Knöös T, McNee SG, et al: Clinical implications of the implementation of advanced treatment planning algorithms for thoracic treatments. Radiother Oncol 86:48-54, 2008
82. Xiao Y, Papiez L, Paulus R, et al: Dosimetric evaluation of heterogeneity corrections for RTOG 0236: Stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 73:1235-1242, 2009
83. Admiraal MA, Schuring D, Hurkmans CW: Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume. Radiother Oncol 86:55-60, 2008
84. Glide-Hurst CK, Hugo GD, Liang J, et al: A simplified method of four-dimensional dose accumulation using the mean patient density representation. Med Phys 35:5269-5277, 2008
85. Guckenberger M, Wilbert J, Krieger T, et al: Four-dimensional treatment planning for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 69:276-285, 2007 (Pubitemid 47247525)
86. Verbakel WF, Senan S, Cuijpers JP, et al: Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensitymodulated arcs. Radiother Oncol 93:122-124, 2009
87. Jackson A, Marks LB, Bentzen SM, et al: The lessons of QUANTEC: Recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. Int J Radiat Oncol Biol Phys 76:S155-S160, 2010 (suppl)
88. Jaffray DA, Lindsay PE, Brock KK, et al: Accurate accumulation of dose for improved understanding of radiation effects in normal tissue. Int J Radiat Oncol Biol Phys 76:S135-S139, 2010 (suppl)
89. Bentzen SM, Parliament M, Deasy JO, et al: Biomarkers and surrogate endpoints for normaltissue effects of radiation therapy: The importance of dose-volume effects. Int J Radiat Oncol Biol Phys 76:S145-S150, 2010 (suppl)
90. Marks LB, Yorke ED, Jackson A, et al: Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76:S10-S19, 2010 (suppl)
91. Marks LB, Bentzen SM, Deasy JO, et al: Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 76:S70-S76, 2010 (suppl)
92. van Baardwijk A, Wanders S, Boersma L, et al: Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stage I-III non - small cell lung cancer. J Clin Oncol 28:1380-1386, 2010
93. Dehing-Oberije C, De Ruysscher D, van Baardwijk A, et al: The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiother Oncol 91:421-426, 2009
94. Werner-Wasik M, Yorke E, Deasy J, et al: Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys 76:S86-S93, 2010 (suppl)
95. De Ruysscher D, Dehing C, Bremer RH, et al: Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol 18:909-916, 2007 (Pubitemid 47054090)
96. Dunlap NE, Cai J, Biedermann GB, et al: Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76:796-801, 2010
97. Pettersson N, Nyman J, Johansson KA: Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non - small cell lung cancer: A dose- and volume-response analysis. Radiother Oncol 91:360-368, 2009
98. Gagliardi G, Constine LS, Moiseenko V, et al: Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 76:S77-S85, 2010 (suppl)
99. Miller KL, Shafman TD, Anscher MS, et al: Bronchial stenosis: An underreported complication of high-dose external beam radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys 61:64-69, 2005
100. Kirkpatrick JP, van der Kogel AJ, Schultheiss TE: Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys 76:S42-S49, 2010 (suppl)
101. Borst GR, Sonke JJ, Betgen A, et al: Kilovoltage cone-beam computed tomography setup measurements for lung cancer patients: First clinical results and comparison with electronic portalimaging device. Int J Radiat Oncol Biol Phys 68:555-561, 2007 (Pubitemid 46694176)
102. Yeung AR, Li JG, Shi W, et al: Tumor localization using cone-beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. Int J Radiat Oncol Biol Phys 74:1100-1107, 2009
103. Bissonnette JP, Franks KN, Purdie TG, et al: Quantifying interfraction and intrafraction tumor motion in lung stereotactic body radiotherapy using respiration-correlated cone beam computed tomography. Int J Radiat Oncol Biol Phys 75:688-695, 2009
104. Guckenberger M, Meyer J, Wilbert J, et al: Cone-beam CT-based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors. Acta Oncol 45:897-906, 2006 (Pubitemid 44423138)
105. Guckenberger M, Meyer J, Wilbert J, et al: Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. Radiother Oncol 83:57-64, 2007 (Pubitemid 46527941)
106. Hoogeman MS, Nuyttens JJ, Levendag PC, et al: Time dependence of intrafraction patient motion assessed by repeat stereoscopic imaging. Int J Radiat Oncol Biol Phys 70:609-618, 2008
107. Green MR, Ginsberg R, Ardizzoni A, et al: Induction therapy for stage III NSCLC: A consensus report. Lung Cancer 11:9-10, 1994 (suppl)
108. Erasmus JJ, Gladish GW, Broemeling L, et al: Interobserver and intraobserver variability in measurement of non - small-cell carcinoma lung lesions: Implications for assessment of tumor response. J Clin Oncol 21:2574-2582, 2003 (Pubitemid 46606340)
109. Mac Manus MP, Hicks RJ, Matthews JP, et al: Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non - small-cell lung cancer. J Clin Oncol 21:1285-1292, 2003 (Pubitemid 46606405)
110. Pöttgen C, Levegrün S, Theegarten D, et al: Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non - small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clin Cancer Res 12:97-106, 2006 (Pubitemid 43166182)
111. Weber WA. Assessing tumor response to therapy. J Nucl Med 50:1S-10S, 2009 (suppl)
112. Ben-Haim S, Ell P: 18F-FDG PET and PET/CT in the evaluation of cancer treatment response. J Nucl Med 50:88-99, 2009
113. National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE), Version 4.0. Bethesda, MD, US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. http://ctep.cancer. gov/protocoldevelopment/electronic-applications/docs/ctcaev4.pdf